Fig. 2.
Representative gel from 11 t(4;14)+patients.
(A) Representative gel of 11 t(4;14)+ patients, with various breakpoints, detected by a JH-ms6r assay. Lane B, negative control. (B) Representative gel of the same 11 patients detected by an Ιμ1-ms6r assay; lane B, negative control. (C) cDNA integrity tests with β2-M primers on the 11 patient samples; lane B, negative control.